Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$998.1M
+73.2% from 2023
Prescriptions
78K
$12,783.10 per claim
Patients
12K
5,016 prescribers
Total spending, 2024
$998.1M
$86,211.12 per patient
Medicare prescription drug plans paid $998.1M for Nubeqa in 2024, for 78,077 prescriptions and refills to 11,577 patients (up 73.2% from 2023). The average cost per claim was $12,783.10.
California had the highest Medicare cost for Nubeqa in 2024: $97.0M for 7,670 claims, followed by New York ($92.9M).
Sukumar Ethirajan, hematology in Overland Park, KS, had the highest Medicare cost for Nubeqa in 2024: 941 claims costing $12.5M.
Nubeqa is made by Bayer Aktiengesellschaft (BAYN.DE), listed in the Medicare spending data as Bayer,Pharm Div.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Sukumar Ethirajan Overland Park, KS | Hematology | 941 | 115 | $12.5M |
| Elan Diamond Bloomfield, NJ | Hematology-Oncology | 812 | 109 | $10.3M |
| Vladimir Hugec |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 2,247 | 26,001 | 4,433 | $322.3M |
| 2023 | 3,461 | 43,908 | 7,170 | $576.2M |
| 2024 | 5,016 | 78,077 | 11,577 | $998.1M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Hematology-Oncology |
| 767 |
| 102 |
| $9.9M |
| William B Townsend Charlotte, NC | Urology | 492 | 69 | $6.4M |
| Ari D Baron San Francisco, CA | Hematology-Oncology | 398 | 50 | $5.3M |
| Ryan J Malone Jeffersonville, IN | Urology | 347 | 48 | $4.6M |
| Joelle P Hamilton Homewood, AL | Medical Oncology | 322 | 52 | $4.0M |
| Eleni Efstathiou Portland, OR | Medical Oncology | 293 | 41 | $3.9M |
| Bryan A Mehlhaff Springfield, OR | Urology | 261 | 38 | $3.4M |
| Arash Rezazadeh Kalebasty Orange, CA | Hematology-Oncology | 249 | 41 | $3.3M |
| John M Rutkowski Sanborn, NY | Urology | 244 | 43 | $3.2M |
| Christian A Thomas Westbrook, ME | Hematology-Oncology | 234 | 38 | $3.2M |
| Alexander Engelman Tampa, FL | Radiation Oncology | 234 | 43 | $3.1M |
| Matthew Rettig Los Angeles, CA | Hematology-Oncology | 220 | 27 | $3.0M |
| Patrick Curran III Boston, MA | Nurse Practitioner | 224 | 42 | $2.9M |
| Tim A Richardson Wichita, KS | Urology | 218 | 27 | $2.9M |
| Timothy J Leroy Knoxville, TN | Urology | 216 | 26 | $2.8M |
| Mary Harlan Tampa, FL | Nurse Practitioner | 207 | 36 | $2.7M |
| David L Taylor Morristown, NJ | Urology | 208 | 35 | $2.7M |
| Paul R Eber Germantown, TN | Urology | 203 | 26 | $2.7M |
| Stephen R Ruyle Denver, CO | Urology | 196 | 28 | $2.7M |
| Iris T Kennedy Little Rock, AR | Nurse Practitioner | 199 | 50 | $2.6M |
| Daniel Fein Milford, MA | Hematology-Oncology | 216 | 27 | $2.6M |
| Christopher M Pieczonka Syracuse, NY | Urology | 193 | 23 | $2.5M |
| Aaron D Berger Chicago Ridge, IL | Urology | 199 | 33 | $2.5M |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Bayer,Pharm Div BAYN.DE | 78,077 | $998.1M |